全文获取类型
收费全文 | 246篇 |
免费 | 17篇 |
专业分类
儿科学 | 12篇 |
妇产科学 | 8篇 |
基础医学 | 15篇 |
口腔科学 | 5篇 |
临床医学 | 27篇 |
内科学 | 77篇 |
皮肤病学 | 5篇 |
神经病学 | 21篇 |
特种医学 | 3篇 |
外科学 | 36篇 |
综合类 | 6篇 |
预防医学 | 4篇 |
药学 | 12篇 |
中国医学 | 1篇 |
肿瘤学 | 31篇 |
出版年
2021年 | 3篇 |
2020年 | 1篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2016年 | 8篇 |
2015年 | 9篇 |
2014年 | 5篇 |
2013年 | 2篇 |
2012年 | 8篇 |
2011年 | 6篇 |
2010年 | 5篇 |
2009年 | 5篇 |
2008年 | 1篇 |
2007年 | 8篇 |
2006年 | 14篇 |
2005年 | 6篇 |
2004年 | 6篇 |
2003年 | 4篇 |
2002年 | 6篇 |
2000年 | 3篇 |
1999年 | 3篇 |
1998年 | 11篇 |
1997年 | 13篇 |
1996年 | 7篇 |
1995年 | 11篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 11篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1987年 | 2篇 |
1986年 | 5篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1971年 | 2篇 |
1970年 | 1篇 |
1967年 | 1篇 |
1958年 | 11篇 |
1957年 | 11篇 |
1956年 | 9篇 |
1955年 | 5篇 |
1954年 | 7篇 |
排序方式: 共有263条查询结果,搜索用时 15 毫秒
71.
72.
73.
Survey of tuberculosis prevalence in Japan, 1953 总被引:1,自引:0,他引:1
YAMAGUCHI M 《Bulletin of the World Health Organization》1955,13(6):1041-1073
74.
75.
YAMAGUCHI KEN; ABE KAORU; ADACHI ISAMU; TANAKA NOBUYOSHI; TANAKA MASAHIRO; MIYAKAWA SUMIKO; KAMEYA TORU; KIMURA TOKIHISA 《Japanese journal of clinical oncology》1977,7(2):111-118
A 48-year-old man with a small cell carcinoma of the lung presentedhyponatremia and was diagnosed as having the syndrome of inappropriateADH secretion. A plasma ADH bioassay confirmed this syndrome.During the clinical course, the patient developed a hyponatremiccrisis with a serum sodium of 108mEq/l. His hyponatremia wasrapidly corrected by infusing furosemide in conjunction withhypertonic saline. The postmortem studies demonstrated ADH bioactivityin the tumor tissues, as well as immunoreactive ACTH, ß-MSHand calcitonin. Tumor hypersecretion of ACTH appeared to bethe cause of the patient's hyperresponsiveness to exogenousACTH and of the bilateral adrenocortical hyperplasia observedat the time of autopsy. Therefore, this was a case of a multiple hormone-producing smallcell carcinoma of the lung, in which the severe clinical manifestationsof SIADH were successfully treated with furosemide and hypertonicsaline. 相似文献
76.
77.
78.
TANAKA MASAHIRO; ABE KAORU; OHNAMI SHUMPEI; ADACHI ISAMU; YAMAGUCHI KEN; MIYAKAWA SUMIKO 《Japanese journal of clinical oncology》1978,8(2):141-148
Patients with advanced breast cancer were treated with antiestrogen,tamoxifen, 20 mg orally, twice a day. Of the evaluable 23 patients,one achieved complete response with a duration of 16 months,and five achieved partial response lasting from two to eightmonths, indicating that the response rate was 26%. In the fiveperi-and postmenopausal patients, basal and LH-RH stimulatedplasma LH levels decreased but stayed within the postmenopausalrange in three patients during the tamoxifen therapy. Basaland LH-RH stimulated FSH levels decreased also but stayed withinthe postmenopausal range in all five patients. In a premenopausalpatient, basal and stimulated plasma LH and FSH levels did notchange significantly during the tamoxifen therapy. The plasmaTSH responses did not change significantly. In three of thesix patients, basal and TRH-stimulated prolactin levels decreasedslightly during the tamoxifen therapy. These relatively inconsistentand small changes in the pituitary hormone secretion observedduring the tamoxifen therapy suggest that the anti-tumor effectof tamoxifen was not due to alteration of the pituitary hormonesecretion. The binding of tamoxifen for the estrogen receptorwas examined in the estrogen receptor assay system. The doseresponse curve for tamoxifen was parallel to that for estradiol,indicating that tamoxifen competes with estradiol for the estrogenreceptor. The affinity constants of tamoxifen for the estrogenreceptor in eight cytosols of human breast cancer tissues were(139 ±79) X 1010M (mean±SD), indicatingthat the binding affinity of tamoxifen was about 0.7% that ofestradiol. The affinity constants for nuclear receptors weresimilar to those for cytosol receptors. These data suggest thattamoxifen is a useful drug for treatment of advanced breastcancer, and that the anti-tumor effect could be related to itsbinding to estrogen receptors in tumor tissues, and not causedby altering the secretion of pituitary hormones. 相似文献
79.
Kentaro INOUE Kenichi MEGURO Kyoko AKANUMA Mitsue MEGURO Satoshi YAMAGUCHI Hiroshi FUKUDA 《Psychogeriatrics》2012,12(1):27-33
Aim: The Clinical Dementia Rating (CDR) is an assessment of dementia severity based on observations of activities of daily living, and a CDR of 0.5 (CDR 0.5) represents questionable dementia. A combination of the Cognitive Abilities Screening Instrument (CASI) and the Trail Making Test (TMT) scores discriminated CDR 0.5 subjects from healthy participants with a high degree of accuracy. We investigated the neurological background of CDR 0.5 subjects by correlating CASI and TMT scores with regional cerebral blood flow (rCBF) as measured by single photon emission computed tomography (SPECT). Methods: From a community‐based cohort, 22 CDR 0.5 participants were recruited. CASI and TMT scores, rCBF measure using [123I]‐N‐isopropyl‐p‐iodoamphetamine and SPECT were obtained. We evaluated the relationships between the CASI domain scores, between TMT scores and rCBF in a regions‐of‐interest‐based analysis, and voxel‐based analysis using Statistical Parametric Mapping 5 software. Results: We found that lower rCBF in the left medial temporal cortex correlated with a decreased CASI domain recent memory score both in the regions‐of‐interest and statistical parametric mapping analysis. In both the regions‐of‐interest and statistical parametric mapping analysis, the rCBF in the left prefrontal cortex correlated with CASI domain remote memory and mental manipulation and concentration. Conclusions: Our results indicate that some CDR 0.5 subjects have functional impairments in the medial temporal lobe as well as in the prefrontal cortex, as reflected in the cognitive decline measured by CASI and TMT. 相似文献